Opko Health (OPK) Total Debt Growth (3y) (2013 - 2026)
Opko Health (OPK) Total Debt Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 5.73% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 10.14% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | -4.73% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 7.07% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 5.11% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -60.49% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -12.66% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -0.64% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 9.58% |
| 10 | Opko Health | 1.01 Bn | 712.28 Mn | 80.02 Mn | 90.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 90.66% |
| Mar 31, 2026 | 119.09% |
| Dec 31, 2025 | 81.91% |
| Sep 30, 2025 | 123.04% |
| Jun 30, 2025 | 139.25% |
| Mar 31, 2025 | 145.60% |
| Dec 31, 2024 | 160.72% |
| Sep 30, 2024 | 158.94% |
| Jun 30, 2024 | 12.84% |
| Mar 31, 2024 | 14.66% |
| Dec 31, 2023 | 12.32% |
| Sep 30, 2023 | 44.10% |
| Jun 30, 2023 | 36.94% |
| Dec 31, 2022 | 64.27% |
| Dec 31, 2021 | -38.48% |
| Sep 30, 2021 | -21.64% |
| Jun 30, 2021 | -16.04% |
| Mar 31, 2021 | -15.70% |
| Dec 31, 2020 | -15.60% |
| Sep 30, 2020 | -34.26% |